DSP and myocarditis: In this report, genotype-positive patients (89% DSP variant carriers) had a significantly higher incidence of the main endpoint (death, ventricular arrhythmias, recurrent episodes of myocarditis and heart failure) than genotype-negative individuals (62.3% vs. 17.5% at 5 years, p < 0.0001) [27].